FINWIRES · TerminalLIVE
FINWIRES

New Zealand Shares Rise; a2 Milk Co. Recalls US Infant Formula Batches After Toxin Detection

By

New Zealand shares ended higher on Monday as most Asian indexes saw gains amid hopes of an easing US-Iran war.

The S&P/NZX 50 Index rose 0.45% or 58.48 points to close at 13,097.68.

US President Donald Trump on Sunday said that the US would begin efforts Monday morning to help free ships stranded in the Strait of Hormuz, describing the move as a humanitarian step to assist neutral countries amid the US-Israeli war with Iran, according to a Sunday Reuters report.

In corporate news, a2 Milk Co. (ASX:A2M, NZE:ATM) started a voluntary recall on May 1 of three batches of its a2 Platinum USA infant milk formula, following the detection of cereulide in product manufactured by Synlait Milk (ASX:SM1, NZE:SML).

Air New Zealand (ASX:AIZ, NZE:AIR) group capacity rose 4.1% year on year in March, and long-haul available seat kilometers (ASKs) rose 2.5%, while domestic ASKs increased by 3.4%.

Related Articles

Asia

Atul Auto's Sales Rise 74% in April

Three-wheeler manufacturer Atul Auto's (NSE:ATULAUTO, BOM:531795) total sales jumped 74% to 3,001 units in April from 1,725 units sold a year ago, according to a Friday filing to the Indian stock exchanges.Of the total, domestic sales grew sharply year-on-year to 2,478 units in April from 1,427 units.

BOM:531795NSE:ATULAUTO
Asia

Leader Education's Fiscal H1 Profit Falls 17%

Leader Education (HKG:1449) booked 20.2 million yuan in attributable profit for the fiscal first half ended Feb. 28, down 17% from 24.2 million yuan a year earlier, according to a Hong Kong bourse filing Sunday.The higher education services company's shares fell nearly 2% in morning trade Monday.Earnings per share were 0.0303 yuan, compared with 0.0363 yuan in the prior-year period.Revenue rose 11% year on year to 191.3 million yuan, figures showed.

HKG:1449
Asia

Market Chatter: CSL, Resmed, Cochlear Lead Losses on ASX

CSL (ASX:CSL) led losses on the Australian bourse so far this year at AU$23.2 billion, while ResMed (ASX:RMD) and Cochlear (ASX:COH) followed with losses of AU$10.6 billion, the Australian Financial Review reported Monday, citing Global X ETFs.Negative performing companies on the S&P/ASX 200 index collectively wiped out over AU$217 billion, said Marc Jocum, senior product and investment strategist at Global X ETFs.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

ASX:COHASX:CSLASX:RMD